Allogene Therapeutics
Allogene Therapeutics
World Rank (Jan-05-2024)
11,801
Market Cap (Jan-05-2024)
0.570 Billion USD
World Rank (Jul-30-2023)
10,537
Market Cap (Jul-30-2023)
0.718 Billion USD
World Rank (Jan-07-2022)
6,446
Market Cap (Jan-07-2022)
1.918 Billion USD
World Rank (Jan-01-2021)
3,859
Market Cap (Jan-01-2021)
3.541 Billion USD
Headquarters Country
Nasdaq / NYSE Code
ALLO
Market Cap (Mar-08-2026)
0.52
Employee Count
310
Employee Count as of Date
As on 2021
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-332 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
817 Million USD
Total Liabilities in USD
151 Million USD
Total Equity in USD
665 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Ads